Natco settles the case with Innovator for GLP 1 and Stelis is the contract manufacturer
A
Thanks. Any commentary on how the Vizag hospital is shaping up? Also, anything on the footfall issue they faced in H2 last year? For context, in the Mar result concall, they had mentioned that they’re changing the marketing agency as the product related marketing had resulted in a surge in the non-care therpay footfalls leading to a loss in rev.
In 2022, SRF had said they will be doing capex of 15000 crore between FY 2024-2028, out of which 12000-13000 was towards chemical, how much of it has been incurred and how much is left?
Wockhardt’s another breakthrough antibiotic: once-a-day β-lactam
enhancer, WCK 6777 with unique out-patient treatment advantage granted
Fast Track designation by US FDA and successfully completes Phase I study
conducted by National Institutes of Health, US
I diagree with the 2nd point opm for samhi would be align with 30 or more in this fiscal year
Shiv Texchem Ltd is set to open its Initial Public Offering (IPO) from October 8, 2024, to October 10, 2024.
We recently had the opportunity to interview their leadership – Mr. Hemanshu Chokhani & Mr. Vikas Pavankumar – https://youtu.be/PQG9Lfhdvto
my bad…since I already sold out before merger I did not get the email and also failed to pickup the screenshot you had posted on your response!
Any further updates on the listing of OCCL Limited?
Hitesh Bhai (@hitesh2710): Look forward to read your latest view on overall markets mood. Any plan to publish anytime soon?
The technical pqttern formed in HCC seems to have failed as of now. The stock price along with the small-midcap carnage has been hit hard.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!